5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes—2023

NA ElSayed, G Aleppo, VR Aroda, RR Bannuru… - Diabetes …, 2023 - Am Diabetes Assoc
The American Diabetes Association (ADA)“Standards of Care in Diabetes” includes the
ADA's current clinical practice recommendations and is intended to provide the components …

Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association

CE Ndumele, J Rangaswami, SL Chow, IJ Neeland… - Circulation, 2023 - Am Heart Assoc
Cardiovascular-kidney-metabolic health reflects the interplay among metabolic risk factors,
chronic kidney disease, and the cardiovascular system and has profound impacts on …

2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of …

G Mancia, R Kreutz, M Brunström, M Burnier… - Journal of …, 2023 - journals.lww.com
Document Reviewers: Luis Alcocer (Mexico), Christina Antza (Greece), Mustafa Arici
(Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luıs Bronze (Portugal), John …

Cardiovascular disease in type 2 diabetes mellitus: progress toward personalized management

CX Ma, XN Ma, CH Guan, YD Li, D Mauricio… - Cardiovascular …, 2022 - Springer
Cardiovascular diseases (CVDs) are the main cause of death among patients with type 2
diabetes mellitus (T2DM), particularly in low-and middle-income countries. To effectively …

A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific statement from the American …

CE Ndumele, IJ Neeland, KR Tuttle, SL Chow… - Circulation, 2023 - Am Heart Assoc
A growing appreciation of the pathophysiological interrelatedness of metabolic risk factors
such as obesity and diabetes, chronic kidney disease, and cardiovascular disease has led …

Prevalence and overlap of cardiac, renal, and metabolic conditions in US adults, 1999-2020

JW Ostrominski, SV Arnold, J Butler… - JAMA …, 2023 - jamanetwork.com
Importance Individually, cardiac, renal, and metabolic (CRM) conditions are common and
leading causes of death, disability, and health care–associated costs. However, the …

SGLT2-inhibitors effects on the coronary fibrous cap thickness and MACEs in diabetic patients with inducible myocardial ischemia and multi vessels non-obstructive …

C Sardu, MC Trotta, FC Sasso, C Sacra… - Cardiovascular …, 2023 - Springer
Background Sodium–glucose transporter 2 inhibitors (SGLT2-I) could modulate
atherosclerotic plaque progression, via down-regulation of inflammatory burden, and lead to …

National trends in use of sodium‐glucose cotransporter‐2 inhibitors and glucagon‐like peptide‐1 receptor agonists by cardiologists and other specialties, 2015 to …

R Adhikari, K Jha, Z Dardari, J Heyward… - Journal of the …, 2022 - Am Heart Assoc
Background Sodium‐glucose cotransporter‐2 inhibitors (SGLT2is) and glucagon‐like
peptide‐1 receptor agonists (GLP‐1RAs) mitigate cardiovascular risk in individuals with type …

Joint association of loneliness and traditional risk factor control and incident cardiovascular disease in diabetes patients

X Wang, H Ma, X Li, Y Heianza… - European Heart …, 2023 - academic.oup.com
Aims To investigate the prospective associations of the loneliness and social isolation
scales with cardiovascular disease (CVD) risk in diabetes patients and compare the relative …

Machine learning in precision diabetes care and cardiovascular risk prediction

EK Oikonomou, R Khera - Cardiovascular Diabetology, 2023 - Springer
Artificial intelligence and machine learning are driving a paradigm shift in medicine,
promising data-driven, personalized solutions for managing diabetes and the excess …